Serial 86839465
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 18 Apr 2025)
What this means for you
Registered since 19 Feb 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86839465
- Registration number
- 5680932
- Mark type
- Design / logo
- Filed
- 04 Dec 2015
- Published for opposition
- 03 May 2016
- Registered
- 19 Feb 2019
- Attorney of record
- Matthew P. Hintz, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of Fabry disease
Owner
- AMICUS THERAPEUTICS, INC., Philadelphia, PA, US
- AMICUS THERAPEUTICS, INC., Cranbury, NJ, US
- AMICUS THERAPEUTICS, INC., Cranbury, NJ, US
Prosecution history
- 18 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 18 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Jan 2025 — TEAS SECTION 8 & 15 RECEIVED
- 19 Feb 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Jan 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Jan 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Jan 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Jan 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Jan 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 May 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 19 Feb 2019 — REGISTERED-PRINCIPAL REGISTER
- 15 Jan 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Jan 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Jan 2019 — STATEMENT OF USE PROCESSING COMPLETE